Novo Nordisk tests China-developed drug for obesity and diabetes while competition is growing
The Danish pharmaceutical giant Novo Nordisk has reported encouraging results from a new diabetes and weight loss drug developed with a Chinese partner, Fierce Biotech reports. The candidate, known as …
Novo Nordisk tests China-developed drug for obesity and diabetes while competition is growing Read More